2-Chloro-5-(chloromethyl)-3-methylpyridine, 98%, 1g

(2E)-1-(3-bromophenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

Iberdomide, 5mg

Ethyl 4-nitro-1H-pyrrole-2-carboxylate, 95.0%, 10g

(4-{[5-(Trifluoromethyl)pyridin-2-yl]oxy}phenyl)methanol, 97.0%, 1g

Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine>97.0%(HPLC)(T)1g

N-Isopropylaminoacetic acid ethyl esterhydrochloride, 98.0%, 500mg

tert-Butyl (5-bromobenzo[d][1,3]dioxol-4-yl)carbamate, 95.0%, 1g

3-(7-Bromo-3-phenylnaphthalen-1-yl)pyridine, 250mg

(1S,5S)-3-methyl-3,6-diazabicyclo[3.2.0]heptane; bis(trifluoroacetic acid), 97.0%, 500mg

6-Morpholin-4-yl-nicotinic acid tert-butyl ester, 95.0%, 1g

Botella de boca estrecha, 250 ml, 12 Pieza(s)

5-Fluorosalicylic acid, 97.0%, 5g